plc, of Dublin, Ireland, appointed Kristine Peterson to its board and named Joseph S. Zakrzewski CEO...Ambit Biosciences Corp., of San Diego, named Faheem Hasnain chairman and appointed Alan Fuhrman chief financial officer...AnaptysBio Inc., of San Diego, named Jan de Vries, Nicholas B. Lydon and Phillip A. Patten to its scientific and therapeutic advisory boards

Roche, of Nutley, N.J., named Jacques Banchereau senior vice president and head of the inflammation and virology discovery and translational areas

Neovacs, of Paris, appointed Florence Hocdee-Leroy communications and investor relations director...Oligomerix Inc., of New York, appointed Vic Micati chairman and named Jack Pasini chief commercial officer and board member

Cytogenix Inc., of New York, appointed Kevin Cassidy and Campbell Murray to its board...Generex Biotechnology Corp., of Worcester, Mass., appointed Mark Fletcher interim president and CEO and named John P. Barratt chairman

Accera Inc., of Broomfield, Colo., appointed Thomas Werner president and CEO...Agile Therapeutics Inc., of Princeton, N.J., named Al Altomari president and CEO...AIKO Biotechnology, of Portland, Maine, appointed Jim New CEO and added Paul Goldenheim to its board

Phosphagenics Ltd., of Melbourne, Australia, appointed Stuart James, Sandra Webb and Don Clarke nonexecutive directors...Regenicin Inc., of New York, added Joseph Rubinfeld and Craig Eagle to its board...Rexahn Pharmaceuticals Inc., of Rockville, Md., appointed Peter Brandt and Richard Kivel to its board

HemoShear LLC, of Charlottesville, Va., added Robert Ruffolo and Kenneth Batchelor to its scientific advisory board...Horizon Discovery Ltd., of Cambridge, UK, appointed Nigel Pitchford and David Evans to its board...NeoStem Inc., of New York, appointed Ian Zhang president and managing director of NeoStem (China) Inc

BioMarin Pharmaceutical Inc., of Novato, Calif., appointed William D. Young and Kenneth M. Bate to its board...Celgene Corp., of Summit, N.J., appointed Jacqualyn A. Fouse senior vice president and chief financial officer...Cubist Pharmaceuticals Inc., of Lexington, Mass., promoted Steven C. Gilman to executive vice president of R&D and chief scientific officer

Aegerion Pharmaceuticals Inc., of Bridgewater, N.J., named Marc Beer CEO and board member...Aquinox Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Csaba Szabo vice president of research and chief scientific officer...AVEO Pharmaceuticals Inc., of Cambridge, Mass., appointed Michael P. Bailey chief commercial officer and Donna M. Radzik vice president of technical operations

in Europe, Asia and Latin America...He previously served as executive vice president of Abbott Corp., of Abbott Park, Ill., and president of its pharmaceutics division, in addtion to group president for Europe and subsequently president of Abbott International

to chief operating officer and David R. Holland to senior vice president of sales and marketing...Myers, Fla., appointed Grant Carlson vice president of business development and named Mark W. Smits vice president of sales and marketing effective Aug. 30, 2010

plc, of Dublin, Ireland, appointed Colin W. Stewart president, CEO and a member of the company's board, effective Aug. 16...Selecta Biosciences Inc., of Watertown, Mass., appointed Werner Cautreels president and CEO...Cautreels most recently served as CEO and global head of R&D at Solvay Pharmaceuticals Inc., acquired earlier this year by Abbott, of Abbott Park, Ill. (See BioWorld Today, Sept. 29, 2009

Celsion Corp., of Columbia, Md., appointed Sid Taubenfeld director of communications and strategic initiatives and named Robert W. Hooper to its board...Dynavax Technologies Corp., of Berkeley, Calif., promoted J. Tyler Martin to president and appointed him to the board

The firm also appointed Ronald Evans and David Mangelsdorf to its scientific advisory board

plc, of Dublin, Ireland, named Eliseo Oreste Salinas executive vice president and chief medical officer...Ikaria Inc., of Clinton, N.J., appointed Martin Meglasson chief science officer, and named Craig Tooman senior vice president and chief financial officer...Hueneme, Calif., appointed Malcolm Gefter to its board and scientific advisory board

Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed Julie A. Caudill vice president of finance and corporate controller...Ambit Biosciences Corp., of San Diego, appointed Alan J. Lewis chairman and CEO...Lewis, who most recently served as president and CEO of the Juvenile Diabetes Research Foundation, has been serving as Ambit's executive chairman since March

The Foundation for the National Institutes of Health appointed Scott Campbell director and CEO...Taris Biomedical Inc., of Lexington, Mass., appointed Sarma Duddu president, CEO and a member of its board...Most recently, Duddu was general manager and vice president of worldwide drug delivery technologies at CIMA Labs Inc, a wholly owned subsidiary of Cephalon Inc., of Frazer, Pa

Probiodrug AG, of Halle, Germany, appointed Claus Braestrup chairman and named Lennart Mucke to its scientific advisory board...Spencer Pharmaceutical Inc., of Boston, named Max Arella president and chairman...YM BioSciences Inc., of Mississauga, Ontario, appointed Nick Glover president and chief operating officer

Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...Bioheart Inc., of Sunrise, Fla., appointed Mike Tomas president, CEO and board member, replacing Karl Groth, who will retain his position as chairman...Jennerex Inc., of San Francisco, appointed Gregory W. Schafer senior vice president and chief financial officer